This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Miltenyi Biotec, Gmbh. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Dan Robin Miller - Innovator in T-Cell Separation Technology
Introduction
Dan Robin Miller is a prominent inventor based in Berlin, Germany, known for his significant contributions to the field of immunology. With a focus on T-cell research, he has developed innovative methods that enhance the identification and separation of non-regulatory T-cells, which are crucial for various therapeutic applications.
Latest Patents
Miller holds a patent for a method titled "Method for the identification and separation of non-regulatory T-cells from a mixture of regulatory T-cells." This invention utilizes the CD154 molecule (CD40 ligand) to deplete CD154+ T-cells from a mixture, allowing for the positive selection of regulatory T-cells using specific markers. The patent also includes a kit designed for detecting CD154 and additional antibodies for identifying activated or non-activated regulatory T-cells.
Career Highlights
Dan Robin Miller is currently associated with Miltenyi Biotec GmbH, a leading company in the field of biotechnology. His work at Miltenyi Biotec has positioned him as a key player in advancing T-cell research and therapeutic methodologies.
Collaborations
Throughout his career, Miller has collaborated with esteemed colleagues, including Anne Schönbrunn and Siegfried Kohler. These partnerships have fostered a collaborative environment that promotes innovation and the development of cutting-edge technologies in immunology.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile